Embera NeuroTherapeutics, Inc. Closes Series A Funding, Starting FDA Trial Process

More info…

Embera NeuroTherapeutics, Inc., a start-up company developing novel treatments for a broad range of addictions, as well as other neuropsychiatric disorders, has secured over $800,000 of Series A financing that will help the company move its novel combinational drug into Phase 1b FDA trials.

Read the full story at http://www.prweb.com/releases/2007/02/prweb503068.htm

meth rehab

We’re Here To Help

Posted in Treatment Center  |  Leave a comment

Leave a reply